Loading…
Sando Pharm (სანდო ფარმა) — a Tbilisi-based pharmaceutical wholesaler / distribution base engaged in wholesale trade of pharmaceutical goods (part of the Sando Group, which also runs the sando.com.ge medicine-comparison platform). Thin distribution margins (~8–15%); revenue declining toward 2023.
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | CAGR |
|---|---|---|---|---|---|---|---|
| Total Revenue | 4,272 | 4,761 | 5,363 | 5,621 | 4,936 | 1,341 | -20.7% |
| Total COGS | 3,798 | 4,361 | 4,790 | 5,045 | 4,197 | 1,209 | -20.5% |
| Gross Profit | 473 | 400 | 573 | 576 | 739 | 132 | -22.6% |
| Gross Margin | 11.1% | 8.4% | 10.7% | 10.3% | 15.0% | 9.8% | |
| 461 | 460 | 522 | 799 | 901 | 439 | -1.0% | |
| EBITDA | 12 | 60 | 51 | 222 | 162 | 307 | nmf |
| EBITDA Margin | 0.3% | 1.3% | 1.0% | 4.0% | 3.3% | 22.9% | |
| Total D&A | 9 | 11 | 15 | 15 | 35 | 43 | +35.7% |
| EBIT / Operating Income | 3 | 71 | 36 | 237 | 198 | 351 | nmf |
| Total Interest Expense | 11 | 13 | 10 | 21 | 30 | 38 | +27.8% |
| Total Other Income | 0 | 0 | 112 | 53 | 125 | 20 | -43.9% |
| Profit Before Tax | 8 | 84 | 138 | 204 | 103 | 369 | +113.0% |
| Total Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | |
| Net Profit / (Loss) | 8 | 84 | 51 | 204 | 103 | 369 | +113.0% |
| Net Margin | 0.2% | 1.8% | 1.0% | 3.6% | 2.1% | 27.5% |
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Ranked by how close each latest revenue is to this one — not a curated comp set. Open this set in Compare →